Radiotherapy Market To Reach $13.65 Billion by 2035

Radiotherapy market is projected to grow from $8.08 billion in 2025 to $13.65 billion by 2035, expanding at a CAGR of 6.0% during the forecast period. This growth is primarily driven by the rising global burden of cancer and increasing adoption of advanced radiotherapy technologies such as proton therapy and image-guided radiotherapy. A major macro driver influencing the market is the rapid increase in cancer incidence globally. According to the World Health Organization, cancer accounted for nearly 10 million deaths in 2022, making it one of the leading causes of mortality worldwide. Furthermore, the WHO estimates that 1 in 5 people will develop cancer during their lifetime, significantly increasing the demand for radiotherapy, which is required in approximately 50–60% of all cancer cases as part of treatment protocols.

Browse the full report description of “Radiotherapy Market Size, Share & Trends Analysis Report, By Product Type (External Beam Radiotherapy Systems, Brachytherapy Systems, Radiotherapy Software, Radiotherapy Accessories), By Technology (IMRT, IGRT, SRT/SBRT, Proton Therapy, 3D-CRT), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Others), By End User (Hospitals, Radiotherapy Centers, Academic Institutes), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/radiotherapy-market

From an end-user perspective, hospitals remain the dominant segment due to infrastructure availability and integration of advanced oncology systems. According to the International Agency for Research on Cancer, the global number of new cancer cases is expected to reach over 35 million by 2050, representing a 77% increase from 2022 levels. This sharp rise in patient volume is pushing healthcare systems to invest in high-throughput radiotherapy systems such as linear accelerators (LINACs) and proton therapy systems.

Among product segments, External Beam Radiotherapy (EBRT) Systems are witnessing the fastest growth due to their widespread adoption, technological advancements, and ability to treat a broad range of cancers. EBRT systems, including IMRT, IGRT, and SBRT technologies, are increasingly preferred due to precision, reduced side effects, and improved treatment outcomes.

Recent Developments

• In January 2026, Ion Beam Applications signed a contract to install a Proteus®ONE proton therapy system at MacKay Memorial Hospital in Taiwan. The deal includes system delivery, installation, and a comprehensive quality assurance package, reinforcing IBA’s market leadership. The facility is expected to begin treating patients by 2029, expanding access to advanced proton therapy.
• In May 2024, Elekta launched the AI-powered Evo CT-Linac with advanced imaging and adaptive radiotherapy capabilities. Unveiled at ESTRO 2024, it enables more precise and personalized cancer treatment. The system also integrates Elekta ONE Planning for faster, AI-driven treatment planning.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technology
  • By Application
  • By End users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Macronix International, Winbond Electronics, Giga Device Semiconductor, Infineon Technologies, Micron Technology, AMIC Technology, Analog Devices, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Radiotherapy Market Segmentation (Validated & Non-Overlapping)

1. By Product Type

• External Beam Radiotherapy (EBRT) Systems
• Internal Radiotherapy (Brachytherapy) Systems
• Radiotherapy Software
• Radiotherapy Accessories

2. By Technology

• Intensity-Modulated Radiotherapy (IMRT)
• Image-Guided Radiotherapy (IGRT)
• Stereotactic Radiotherapy (SRT/SBRT)
• Proton Beam Therapy
• 3D Conformal Radiotherapy (3D-CRT)

3. By Application

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Head & Neck Cancer
• Brain Tumors
• Cervical Cancer
• Others (pancreatic, skin, etc.)

4. By End User

• Hospitals
• Independent Radiotherapy Centers
• Academic & Research Institutes

Global Radiotherapy Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/radiotherapy-market